Imaging News

Imagen Technologies, Inc. announced the FDA issued 510(k) clearance of the company’s cloud-based, deep learning software to assist in the detection of aortic atherosclerosis and aortic ectasia on chest X-rays.

Artificial intelligence decision support vs. sonographer on timing and accuracy of assessment of echocardiograms.

CHICAGO — In people without diabetes or significant HF, 6 months of empagliflozin treatment was not associated with any meaningful changes in cardiac remodeling indices compared with placebo, according to data from the EMPA-HEART 2 study.

In suspected obstructive CAD, clinical models with risk factors and a coronary artery calcium score identified up to 3.5 times more patients who may not benefit from further diagnostic testing vs. a basic pretest probability model.

CHICAGO — In stable patients with ischemia, there was no difference between an invasive strategy and a conservative strategy of optimal medical therapy in mortality at 5.7 years, according to results of the ISCHEMIA-EXTEND study.

CHICAGO — In stable symptomatic patients with suspected CAD, a precision testing strategy was linked to a 70% reduction in death, MI or catheterization without obstructive CAD at 1 year compared with the usual testing, researchers reported.

Prior SARS-CoV-2 infection was associated with coronary vasomotor dysfunction, regardless of whether the patient required hospitalization, according to a brief communication published in the Journal of the American Heart Association.

In adults with intermediate, high or extreme operative risk who underwent transcatheter aortic valve replacement, left ventricular stroke volume index 30 days after TAVR was an early predictor of 1‐year mortality, data show.

LDL reduction is the major focus in the primary and secondary prevention of atherosclerotic CVD.

HeartFlow announced it has received FDA 510(k) clearance on two new noninvasive artificial intelligence-powered coronary artery anatomy and plaque analyses based on coronary CT angiography.